Country: Sweden
Gambro: Advancing Innovation in Renal Care

In 2013, Baxter International acquired Gambro, making the Swedish medical technology company a wholly owned subsidiary and strengthening Baxter’s global presence in renal therapy and related healthcare services.

Gambro is recognized worldwide for developing, manufacturing, and supplying advanced products, therapies, and services for in-center and self-care hemodialysis, peritoneal dialysis, renal intensive care, and hepatic care. Over the decades, the company has played a pioneering role in renal care innovation, introducing several groundbreaking technologies to the market.

As the only clinic-independent company in its field, Gambro focuses on delivering complete solutions for dialysis clinics and intensive care units. Its integrated approach not only improves treatment quality and patient outcomes but also enhances operational efficiency for healthcare providers worldwide.